Clinical Efficacy and Cost Effectiveness of MYCOPD in Patients With Mild and Moderate Newly Diagnosed COPD (EARLY)
Evidence Generation for the Clinical Efficacy and Cost Effectiveness of myCOPD in Patients With Mild and Moderate Newly Diagnosed COPD
Sponsor: Central London Community Healthcare NHS Trust
Listed as NCT03620630, this NA trial focuses on COPD and remains completed. Sponsored by Central London Community Healthcare NHS Trust, it has been updated 8 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Mar 2020 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Dec 2019 — Mar 2020 [monthly]
Active Not Recruiting NA
▶ Show 3 earlier versions
-
Sep 2019 — Dec 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Dec 2018 — Sep 2019 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2018 — Dec 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Central London Community Healthcare NHS Trust
- Hampshire Hospitals NHS Foundation Trust
- Hull University Teaching Hospitals NHS Trust
- Imperial College London
- Innovate UK
- my mhealth Ltd
For direct contact, visit the study record on ClinicalTrials.gov .